Dr. Robert Snyder explains that a new drug, Dupixent, was recently FDA approved to treat people 12 years of age and older with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies.